Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLLS Cellectis S.A.

盘前交易 12-23 08:36:22 EST

1.64

+0.05

+3.14%

最高1.64	最低1.53	成交量8.79万
今开1.58	昨收1.59	日振幅6.92%
总市值1.64亿	流通市值1.17亿	总股本1.00亿
成交额13.94万	换手率0.12%	流通股本7,146万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis S.A.","latestPrice":1.64,"timestamp":1734728400000,"preClose":1.59,"halted":0,"volume":87886,"delay":0,"floatShares":71463341,"shares":100093873,"eps":-1.035365,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.05,"latestTime":"12-23 08:36:22 EST","open":1.58,"high":1.64,"low":1.53,"amount":139430.435912,"amplitude":0.069182,"askPrice":2.19,"askSize":100,"bidPrice":1.58,"bidSize":158,"shortable":3,"etf":0,"ttmEps":-1.035365,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":1,"listingDate":1427256000000,"adjPreClose":1.64,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.64,"latestTime":"16:00 EST","volume":50,"amount":82,"timestamp":1734728402303},"volumeRatio":1.4644200882220675,"impliedVol":1.5169,"impliedVolPercentile":0.952},"requestUrl":"/m/hq/s/CLLS/wiki","defaultTab":"wiki","newsList":[{"id":"2492015960","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492015960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492015960?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:44","pubTimestamp":1734554694,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时44分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅跳水5.28%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为3.01%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044454984cb917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044454984cb917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2491337051","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491337051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491337051?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:20","pubTimestamp":1734106859,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时20分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速下挫5.41%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.48%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214002059ab75be8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214002059ab75be8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2490019318","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘快速上涨6.54%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490019318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490019318?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841061,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速拉升6.54%。截至发稿，该股报2.09美元/股，成交量1811股，换手率0.00%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.25%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223101ab6cf501&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223101ab6cf501&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2489442181","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489442181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489442181?lang=zh_cn&edition=full","pubTime":"2024-12-05 04:34","pubTimestamp":1733344452,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日04时34分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.61%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.52%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205043412a1d466a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205043412a1d466a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2487755018","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487755018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487755018?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:31","pubTimestamp":1732890716,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速跳水5.10%。截至发稿，该股报2.02美元/股，成交量3343股，换手率0.00%，振幅0.20%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.12%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223156a25f74e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223156a25f74e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2486603888","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.10%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486603888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486603888?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:49","pubTimestamp":1732636187,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时49分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅上涨5.10%。截至发稿，该股报2.06美元/股，成交量6.6871万股，换手率0.07%，振幅3.06%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623494798e44b5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623494798e44b5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2486103257","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速上涨5.35%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486103257?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:30","pubTimestamp":1732552219,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时30分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速上涨5.35%。截至发稿，该股报1.97美元/股，成交量3.296万股，换手率0.03%，振幅4.81%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003020a254c4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126003020a254c4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2484988338","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.35%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484988338?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:27","pubTimestamp":1731958073,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时27分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速上涨5.35%。截至发稿，该股报1.97美元/股，成交量17.0066万股，换手率0.17%，振幅6.42%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032753971a7429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119032753971a7429&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2483056163","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.24%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483056163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483056163?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:45","pubTimestamp":1731685503,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时45分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速跳水5.24%。截至发稿，该股报1.81美元/股，成交量6741股，换手率0.01%，振幅5.24%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为3.26%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523450398e42fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111523450398e42fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2483388111","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌6.06%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388111?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:34","pubTimestamp":1731598487,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时34分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅跳水6.06%。截至发稿，该股报1.86美元/股，成交量2177股，换手率0.00%，振幅2.33%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.75%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233448a237f447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114233448a237f447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4139","BK4007","PULM","CLLS","ELAB"],"gpt_icon":0},{"id":"2482732807","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482732807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482732807?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:18","pubTimestamp":1731341896,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时18分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅上涨5.08%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.00%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001816971a5c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112001816971a5c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2482979427","title":"Cellectis Ads Each Repr 1 Ord Spon2024财年第三财季实现净利润-23.06百万美元，同比减少31.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482979427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482979427?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:03","pubTimestamp":1731168228,"startTime":"0","endTime":"0","summary":"11月10日，Cellectis Ads Each Repr 1 Ord Spon公布财报，公告显示公司2024财年第三财季净利润为-23.06百万美元，同比减少31.92%；其中营业收入为16.20百万美元，同比增加10351.61%，每股基本收益为-0.23美元。从资产负债表来看，Cellectis Ads Each Repr 1 Ord Spon总负债2.66亿美元，其中短期债务13.86百万美元，资产负债比为1.49，流动比率为1.78。机构评级：截至2024年11月10日，当前有7家机构对Cellectis Ads Each Repr 1 Ord Spon目标价做出预测，其中目标均价为6.29美元，其中最低目标价为3.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000453a22787aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000453a22787aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS"],"gpt_icon":0},{"id":"2481886766","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481886766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481886766?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817077,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速拉升7.95%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Elevai Labs, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃，换手率分别为2181.06%、847.64%、395.62%，振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Renovaro Inc.，振幅分别为25.26%、9.88%、7.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522311795bdd1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522311795bdd1b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2479259155","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘股价大跌6.74%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479259155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479259155?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:57","pubTimestamp":1730231861,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时57分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速跳水6.74%。截至发稿，该股报1.80美元/股，成交量19.1522万股，换手率0.19%，振幅6.74%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030035741971a301d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030035741971a301d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2478262930","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速下跌5.22%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478262930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478262930?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:36","pubTimestamp":1729870565,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时36分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速跳水5.22%。截至发稿，该股报1.80美元/股，成交量8406股，换手率0.01%，振幅3.49%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.61%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025233605971a25dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025233605971a25dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2477552434","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.00%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477552434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477552434?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:46","pubTimestamp":1729705573,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时46分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅拉升5.00%。截至发稿，该股报1.89美元/股，成交量24.0893万股，换手率0.24%，振幅5.53%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为1.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024014614ab6df5f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024014614ab6df5f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"gpt_icon":0},{"id":"2474225018","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速上涨5.10%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225018?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:46","pubTimestamp":1728481595,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时46分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速拉升5.10%。截至发稿，该股报2.06美元/股，成交量6245股，换手率0.01%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.66%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092146369719f44b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092146369719f44b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","IKT","BK4139"],"gpt_icon":0},{"id":"2473109325","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨8.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473109325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473109325?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:41","pubTimestamp":1728308496,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时41分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速拉升8.69%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.06%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721413798e3ada1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721413798e3ada1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0},{"id":"2472461680","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘急速上涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472461680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472461680?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:32","pubTimestamp":1727962339,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时32分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速拉升6.12%。截至发稿，该股报2.08美元/股，成交量1099股，换手率0.00%，振幅0.51%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.27%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003213220958dc5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003213220958dc5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183","BK4139","CLLS"],"gpt_icon":0},{"id":"2472558170","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘快速下跌5.10%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472558170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472558170?lang=zh_cn&edition=full","pubTime":"2024-10-02 03:41","pubTimestamp":1727811714,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日03时41分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.01美元/股，成交量3.4414万股，换手率0.03%，振幅5.19%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203415498e3a07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203415498e3a07c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":-0.0682},{"period":"1month","weight":-0.1414},{"period":"3month","weight":-0.2734},{"period":"6month","weight":-0.1323},{"period":"1year","weight":-0.5134},{"period":"ytd","weight":-0.4675}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectis S.A.于2000年1月4日成立。该公司是一家处于临床阶段的生物技术公司，利用他们的核心专有技术开发基于基因编辑的产品，拥有一系列同种异体嵌合抗原受体T细胞，即免疫肿瘤学领域的候选产品和基因编辑造血干细胞和祖细胞，即HSPC，其他治疗适应症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.004346},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.066082},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.033625},{"month":4,"riseRate":0.3,"avgChangeRate":-0.001702},{"month":5,"riseRate":0.7,"avgChangeRate":0.070474},{"month":6,"riseRate":0.2,"avgChangeRate":-0.087784},{"month":7,"riseRate":0.3,"avgChangeRate":-0.01954},{"month":8,"riseRate":0.7,"avgChangeRate":0.059564},{"month":9,"riseRate":0.1,"avgChangeRate":-0.130295},{"month":10,"riseRate":0.4,"avgChangeRate":-0.073969},{"month":11,"riseRate":0.5,"avgChangeRate":0.248898},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012219}],"exchange":"NASDAQ","name":"Cellectis S.A.","nameEN":"Cellectis SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectis S.A.,CLLS,Cellectis S.A.股票,Cellectis S.A.股票老虎,Cellectis S.A.股票老虎国际,Cellectis S.A.行情,Cellectis S.A.股票行情,Cellectis S.A.股价,Cellectis S.A.股市,Cellectis S.A.股票价格,Cellectis S.A.股票交易,Cellectis S.A.股票购买,Cellectis S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}